Search

Search Results

• 

  The treatment of venous thromboembolism with new oral anticoagulants

  Davide Imberti

  29-35

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.29

  1232

  PDF: 975
• 

  REACH, PATHOS and SIRIO: indications for managing atherothrombosis

  Davide Imberti, Matteo Giorgi Pierfranceschi, Enrico Sverzellati, Sergio Orlando

  35-40

  03-05-2013

  https://doi.org/10.4081/itjm.2008.2.35

  1057

  PDF: 1787
• 

  Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  8-21

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.8

  1536

  PDF: 1054
• 

  Agranulocytosis: an adverse effect of allopurinol treatment

  Elisa Mari, Franco Ricci, Davide Imberti, Massimo Gallerani

  120-123

  07-03-2013

  https://doi.org/10.4081/itjm.2011.120

  1764

  PDF: 1814
• 

  How to manage new oral anticoagulants in case of surgery

  Davide Imberti

  36-40

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.36

  1100

  PDF: 926
• 

  Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, Niccolò Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  153-169

  23-10-2012

  https://doi.org/10.4081/itjm.2012.153

  1871

  PDF: 2279

• A case report of bladder cancer-related acquired hemophilia A

  Gaia Dragoni, Nicolò Ferraroni, Raffaella Benedetti, Aderville Cabassi, Davide Imberti

  17-06-2025

  https://doi.org/10.4081/itjm.2025.2019

  611

  PDF: 368

  HTML: 60